Applications for Microfluidic Technologies in Point of Care Testing: 2014 Report - KAIT-Jonesboro, AR-News, weather, sports

Applications for Microfluidic Technologies in Point of Care Testing: 2014 Report

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, July 14, 2014 /PRNewswire/ --Research and Markets has announced the addition of the "Point of Care Testing 2014: Applications for Microfluidic Technologies" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

POC testing based on microfluidic technology is expected to grow sharply, from $1.6B in 2013 to $5.6B in 2019, at a CAGR 2014 - 2019 of 23%. Major diagnostics companies (Alere, Abbott Point of Care, BD Diagnostics, Cepheid, Abaxis, etc.) have realized the potential of rapid molecular diagnostic testing.

Indeed, several successful Point of Care products based on microfluidic technology have been launched in the past few years. Access to microfluidic technologies for diagnostic companies often passes through acquisitions, as this reduces the technology development risk and increases reactivity. The most recent acquisition was that of IQuum by Roche for $275M in April 2014.

Based on a complete analysis of the last three years' developments, we have been able to draw effective conclusions. Despite slower than expected growth in 2012, we explain why strong future growth is still likely.

POC 2014 report describes the following applications:

  • Emergency testing
  • Home tests
  • Doctor's office screening
  • Decentralized hospital tests
  • Environmental testing
  • Forensic and military
  • Third-world infections
  • Agro-food

Each of these are explained using market data, trends and drivers, key players and technologies used.

Also, growth perspectives and a value chain analysis are detailed for each application, and examples of innovative products are provided.

Moreover, this new report provides an overview of nearly 65 new technologies (commercialized or close to market), with information regarding commercial status, targeted application, technology description, sample volume, sensitivity level and target price

Key Topics Covered:

Executive summary

Introduction

The market for Point of Care diagnostics

What's happened since 2011?

Market segmentation

Point of Care technologies

Success stories analysis

POC challenges

Supply and value chain

Outlook

Summary and conclusions

Companies Mentioned:

  • 3M
  • Abaxis
  • Abbott Point of Care
  • Accumetrics
  • Achira
  • Akonni Biosystems
  • Alere
  • Ativa
  • Bio-Rad
  • BioCartis
  • Biodetection Instruments
  • Cepheid
  • Curetis
  • DNA Electronics
  • Daktari
  • Enigma Diagnostics
  • F-Cubed
  • Focus Diagnostic
  • GenePOC
  • Genefluidics
  • Great Basin
  • Handylab (BD)
  • IBM
  • INO
  • Ikerlan
  • Iquum
  • Johnson & Johnson (Amic)
  • LeukoDX
  • Lumora
  • MIT Lincoln Laboratory
  • Medimate
  • Molbio Diagnostics
  • Molecular Vision (Abingdon Health)
  • Nanosphere
  • NetBio
  • Norchip
  • OPKO Diagnostics
  • OcuSense
  • On-Chip Biotechnologies
  • Pall Corporation
  • Philips
  • Rheonix
  • Roche
  • STMicroelectronics
  • Siemens
  • Smiths Detection
  • Sony (Micronics)
  • SpinChip Diagnostics AS
  • ThermoFisher
  • Vista Therapeutics
  • Wako Diagnostics
  • Zyomyx Inc
  • bioMérieux

For more information visit http://www.researchandmarkets.com/research/x2l8qm/point_of_care

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

472 Craighead Co. 766
Jonesboro, AR 72401
(870) 931-8888

FCC Public File
publicfile@kait8.com
(870) 336-1816
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KAIT. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.